Herbal Medicines and their Metabolites for Infectious Diseases – Computational and Pharmacological Approaches

  • 900

    Total Views and Downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 12 April 2025

  2. This Research Topic is still accepting articles.

Background

Herbal medicines and individual metabolites isolated from them offer multiple opportunities in the treatment and management of infectious diseases , which in recent has years become increasingly important. For example, new treatment options are needed in the face of increasing antimicrobial resistance and emerging viral threats. Infectious diseases such as COVID-19, influenza, dengue, Zika, hepatitis B and C, Ebola, monkeypox, and the herpes simplex virus (HSV) continue to pose a major challenge to global health. Traditionally, medicines derived from plants, microorganisms, and marine sources have provided a rich source of pharmacologically active compounds. The rapid emergence of drug resistance and mutations seen in various viral infections has created an urgent need for novel treatments. Natural products have long been a valuable resource in drug discovery as they offer complex chemical structures with high bioactivity. However, traditional drug discovery methods are time-consuming and labour-intensive.

Computational approaches such as molecular docking, virtual screening, and machine learning offer opportunities in drug discovery process by identifying potential drug candidates faster and more efficiently. However, the current in silico methods used have multiple methodological and conceptual flaws, which often result in meaningless outcomes. For example, false positive or false negative outcomes of previous studies impact on all approaches using the evidence based on the existing scientific literature, and must be taken into account. Many compounds including for example polyphenols shown non-specific, therapeutically non-relevant effects in in silico and in vitro studies. As a consequence purely computational studies are generally misleading, especially if they are used with complex mixtures like plant extracts and a combination of experimental and in silico approaches offers new opportunities

These combinations of computational and pharmacological strategies have the potential assist with scientific developments in the diverse field of infectious diseases including viral infections and to overcome drug resistance mechanisms. This area of research plays a crucial role in the ongoing global effort to develop effective treatments for a variety of infectious diseases.

The main objective of this research topic is to identify and develop plant and fungal metabolites and extracts with potent therapeutic activity against infectious diseases, including the conditions listed above.

Recent advances in computational approaches such as molecular docking, pharmacophore modelling, and machine learning offer novel in silico approaches. These methods enable the rapid but preliminary screening of vast chemical libraries derived from natural sources and identify potential drug candidates. However, there are multiple conceptual and methodological problems which need to be overcome and purely in silico approaches most notably with extracts mostly result in non-usable results. Combining these computational techniques with pharmacological in vitro or in vivo can improve the discovery process of antiviral agents with novel mechanisms of action. In addition, advances in structural biology, omics technologies, and in silico modelling provide deeper insights into the molecular interactions between metabolites, which are already known to show activity and viral targets. This integrative approach has the potential to accelerate the development of safe, effective, and affordable therapies for infectious diseases.

Scope of the Research Topic:

1. Combined computational and pharmacological approaches to natural drug discovery for infectious diseases, including but not limited to COVID-19, influenza (flu), dengue virus, Zika virus, hepatitis B and C viruses, Ebola virus, monkeypox, and herpes simplex virus (HSV).

2. Identification, characterization, and optimization of medicinal plant and fungal extracts for infectious diseases.

3. Preclinical and clinical studies of natural medicines for infectious diseases.

4. Combination therapies with natural medicines for infectious diseases.

5. Identification of novel leads derived from plants and fungi to treat infectious diseases

6. Improved drug delivery and formulation approaches for natural medicines.

Important Note:

All contributions to this Research Topic must follow the guideline listed in this section:
• Purely in silico/AI-based studies are outside of our scope.
• The introduction needs to describe the background of the research object focusing on the traditional or local use of a traditional medicine and provide bibliographical references that illustrate its recent application in general healthcare.
• Network studies must critically assess the pharmacological evidence to evaluate the potential effects of a preparation / herbal (medical) product and the limitations of the evidence. An in vitro or in vivo assessment needs to be an integrated part of the study
• Chemical anti-oxidant assays like the DPPH or ABTS assay are of no pharmacological relevance, Therefore they can only be used a chemical-analytical assays without pharmacological claims.
• Please self-assess your MS using the ConPhyMP tool (https://ga-online.org/best-practice) and submit the relevant sections of the tool with your submission. You need to follow the standards established in the ConPhyMP statement Front. Pharmacol. 13:953205).
• All the manuscripts need to fully comply with the Four Pillars of Best Practice in Ethnopharmacology (you can freely download the full version here). Importantly, please ascertain that the ethnopharmacological context is clearly described (pillar 3d) and that the material investigated is characterized in detail (pillars 2 a and b).

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Clinical Trial
  • Data Report
  • Editorial
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion
  • Original Research

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Infectious diseases, Natural compounds, Artificial intelligence, Bioinformatics (computational biopharmaceutics and modeling), Pharmaceutical Chemistry, Network Pharmacology

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 900Topic views
View impact